Evidence map›Paper›PMID 40719953›Full record

ArticleJournal of endocrinological investigation2025

Serum Wnt1-Inducible signalling pathway Protein-1 levels are associated with cerebral infarction in patients with type 2 diabetes mellitus.

Yan Zhu, Qionglei Fang, Yingyi Zhou, Wen Lu, Xuan Du, Bimin Shi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yan Zhu *Department of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Qionglei Fang *Department of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Yingyi ZhouDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Wen LuDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Xuan DuDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. cathy-dx0630@163.com.ORCID http://orcid.org/0000-0003-4584-7400
Bimin ShiDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. SDshibimin@163.com.ORCID http://orcid.org/0009-0006-7688-2283

Funding

National Key R&D Program of China 2019YFA0802400Science and Technology Program of Suzhou SKY2022125
6 · The paper itself

Abstract

purposeTo investigate the correlation between serum Wnt1-inducible signalling pathway protein-1 (WISP-1) levels and cerebral infarction (CI) in patients with type 2 diabetes (T2DM).

methodsThis was a cross-sectional study. We enrolled 87 patients with T2DM (T2DM group) and 83 T2DM patients with cerebral infarction (DCI group) who were admitted to the First Affiliated Hospital of Soochow University. Serum WISP-1 levels were assessed via an enzyme-linked immunosorbent assay (ELISA). Differences in general statistics, biochemical parameters, islet function, and serum WISP-1 levels were compared between the two groups. The associations between the WISP-1 levels and other parameters and the influences of various parameters on the risk of cerebral infarction were analysed.

resultsThe level of WISP-1 in the DCI group (204.87 ± 32.02 pg/ml) was greater than that in the T2DM group (191.57 ± 33.36 pg/ml) (p < 0.05). Multiple logistic regression analysis revealed that the WISP-1 level, age and HDL-C level were independent factors associated with the occurrence of cerebral infarction in T2DM patients (p < 0.05 and p < 0.01, respectively). The area under the ROC curve of serum WISP-1, age and HDL-C for CI in T2DM patients was 0.797 (0.731-0.863, p < 0.01). Spearman correlation analysis revealed that the WHR and HbA1c, Cr and VitD levels were positively correlated with serum WISP-1 levels (r = 0.237, r = 0.153, r = 0.165 and r = 0.164, respectively, p < 0.05) and that the WHR and HbA1c and VitD levels were independently correlated with WISP-1.

conclusionA high WISP-1 level is an independent risk factor for cerebral infarction in T2DM patients. WISP-1 levels are affected by the WHR and HbA1c and VitD levels.

Indexed as

BiomarkersCCN Intercellular Signaling ProteinsCerebral InfarctionDiabetes Mellitus, Type 2Proto-Oncogene ProteinsAgedCross-Sectional StudiesFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisRisk FactorsBiomarkersCCN4 protein, humanCCN Intercellular Signaling ProteinsProto-Oncogene ProteinsCerebral infarctionRisk factorType 2 diabetesWISP-1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.